GE Healthcare and Microsoft announce a cloud-based COVID-19 patient monitoring tool for hospitals; all but the installation costs will be waived until 2021
GE Healthcare is extending its longtime collaboration with Microsoft to launch a cloud-based COVID-19 patient monitoring software for health systems.
Context & Ripple Effects
GE Healthcare and Microsoft are reuniting on clinical software four years after GE bought out Microsoft's half of their Caradigm joint venture — this time around a cloud-based COVID-19 patient monitoring tool that hospitals can deploy at no charge beyond installation until 2021.
The giveaway lands mid-crisis: weeks earlier the UK's NHS had already pulled Microsoft, Google, Palantir, and Faculty AI into a virus-spread and capacity dashboard, making hospitals the most actively contested ground between cloud vendors right now.
First-order effects
- Hospitals straining under COVID-19 caseloads gain remote patient monitoring with no software licensing cost through 2021, lowering the barrier to digitizing wards during the surge.
- Microsoft regains a direct bedside presence in clinical settings via GE Healthcare's installed hospital base, rather than selling infrastructure alone.
Second-order effects
- The waived pricing functions as a land-grab: when charges resume in 2021, participating hospitals face switching costs just as Microsoft productizes the stack in its Cloud for Healthcare suite of telehealth and engagement tools.
- Rivals are answering in kind — Google's subsequent partnership with HCA Healthcare to build patient-monitoring and efficiency algorithms shows cloud competitors bidding for the same hospital data relationships.
Third-order effects
- If the pattern holds, crisis-era free deployments convert health systems into structurally dependent cloud customers, shifting vendor lock-in from medical devices and EHRs toward the underlying cloud platform.
- Public-health bodies working with these vendors, as the NHS dashboard arrangement shows, will face growing scrutiny over how much pandemic-response data concentrates with a small set of US cloud companies.
The trend: The pandemic is accelerating health systems' migration onto hyperscaler clouds, with free crisis tooling serving as the entry wedge before paid contracts begin.